WHO ICTRP trial
The phase I,II clinical study of cancer vaccine for intractable malignant tumor…
JPRN-UMIN000001999 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000001999 |
|---|---|
| Public title | The phase I,II clinical study of cancer vaccine for intractable malignant tumor expressing MAGE-A4-antigen |
| Scientific title | The phase I,II clinical study of cancer vaccine for intractable malignant tumor expressing MAGE-A4-antigen - The clinical study of cancer vaccine for intractable malignant tumor |
| Primary sponsor | Department of Surgical Oncology, Hokkaido University Graduate School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase I,II |
| Countries | Japan |
| Conditions | Intractable malignant tumors expressing MAGE-A4 antigen |
| Interventions | CHP-MAGE-A4 injection of 100 µg CHP-MAGE-A4 injection of 300 µg CHP-MAGE-A4 injection of 300 µg and concomittant injection of OK-432 as an adjuvant |
| Registration date | May 22, 2009 |
| Target size | 18 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: